AZN icon

AstraZeneca

1,372 hedge funds and large institutions have $45.1B invested in AstraZeneca in 2025 Q4 according to their latest regulatory filings, with 243 funds opening new positions, 490 increasing their positions, 411 reducing their positions, and 120 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
1,372
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
21
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$591M
Puts
$420M
Net Calls
Net Calls Change

Top Buyers

1 +$420M
2 +$412M
3 +$327M
4
Citigroup
Citigroup
New York
+$204M
5
Barclays
Barclays
United Kingdom
+$180M

Top Sellers

1 -$924M
2 -$831M
3 -$550M
4
Primecap Management
Primecap Management
California
-$258M
5
Citadel Advisors
Citadel Advisors
Florida
-$241M
Name Holding Trade Value Shares
Change
Change in
Stake
AIC
1401
Aurora Investment Counsel
Georgia
HI
1402
Horizon Investments
North Carolina
OC
1403
Oppenheimer & Co
New York
EF
1404
Empowered Funds
Pennsylvania
LFAS
1405
Level Four Advisory Services
Texas
BCA
1406
Bay Colony Advisors
Massachusetts
EGM
1407
Engineers Gate Manager
New York
LIP
1408
Lighthouse Investment Partners
Florida
Optiver Holding
1409
Optiver Holding
Netherlands
GIC
1410
Generali Investments CEE
Czech Republic
NSEDCP
1411
NJ State Employees Deferred Compensation Plan
New Jersey
P
1412
Pitcairn
Pennsylvania
BHCM
1413
Brevan Howard Capital Management
Jersey
CLGM
1414
Capitolis Liquid Global Markets
New York
LFA
1415
Legacy Financial Advisors
Kentucky
SMH
1416
Sanders Morris Harris
Texas
MIP
1417
Marietta Investment Partners
Wisconsin
SN
1418
Sittner & Nelson
Oregon
BFM
1419
Boothbay Fund Management
New York
WWM
1420
Whalen Wealth Management
Nevada
RCA
1421
Riverview Capital Advisers
Massachusetts
HSA
1422
HBK Sorce Advisory
Pennsylvania
OAC
1423
OMERS Administration Corp
Ontario, Canada
CT
1424
Coastline Trust
Rhode Island
HCM
1425
Howland Capital Management
Massachusetts